Atlas Trials

Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates

Clinical trial NCT01911728 · COMPLETED

Trial details

NCT number
NCT01911728
Sponsor
Astellas Pharma Europe B.V.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pharmacokinetics of MDV3100Castration Resistant Prostate Cancer (CRPC)
Start date
2011-07-25
Primary completion
2012-02-21
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.